New Results
Impaired Therapeutic Efficacy of Bone Marrow Cells from Post-Myocardial Infarction Patients in the TIME and LateTIME Clinical Trials
Xiaoyin Wang, Ronak Derakhshandeh, Hilda J. Rodriguez, Daniel D. Han, Dmitry S. Kostyushev, Timothy D. Henry, Jay H. Traverse, Lem Moyé, Robert D. Simari, Doris A. Taylor, View ORCID ProfileMatthew L. Springer
doi: https://doi.org/10.1101/721860
Xiaoyin Wang
1Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA
Ronak Derakhshandeh
1Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA
Hilda J. Rodriguez
2Division of Cardiology, University of California, San Francisco, San Francisco, CA 94143, USA
8Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA
Daniel D. Han
2Division of Cardiology, University of California, San Francisco, San Francisco, CA 94143, USA
Dmitry S. Kostyushev
2Division of Cardiology, University of California, San Francisco, San Francisco, CA 94143, USA
Timothy D. Henry
3The Christ Hospital, Cincinnati, OH, USA
Jay H. Traverse
4Minneapolis Heart Inst Fndn, Minneapolis, MN, USA
Lem Moyé
5University of Texas Health School of Public Health, Houston, TX, USA
Robert D. Simari
6Kansas University Medical Center, Kansas City, KS, USA
Doris A. Taylor
7Texas Heart Institute, Houston, TX, USA
Matthew L. Springer
1Cardiovascular Research Institute, University of California, San Francisco, San Francisco, CA 94143, USA
2Division of Cardiology, University of California, San Francisco, San Francisco, CA 94143, USA
8Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA 94143, USA
Article usage
Posted August 01, 2019.
Impaired Therapeutic Efficacy of Bone Marrow Cells from Post-Myocardial Infarction Patients in the TIME and LateTIME Clinical Trials
Xiaoyin Wang, Ronak Derakhshandeh, Hilda J. Rodriguez, Daniel D. Han, Dmitry S. Kostyushev, Timothy D. Henry, Jay H. Traverse, Lem Moyé, Robert D. Simari, Doris A. Taylor, Matthew L. Springer
bioRxiv 721860; doi: https://doi.org/10.1101/721860
Impaired Therapeutic Efficacy of Bone Marrow Cells from Post-Myocardial Infarction Patients in the TIME and LateTIME Clinical Trials
Xiaoyin Wang, Ronak Derakhshandeh, Hilda J. Rodriguez, Daniel D. Han, Dmitry S. Kostyushev, Timothy D. Henry, Jay H. Traverse, Lem Moyé, Robert D. Simari, Doris A. Taylor, Matthew L. Springer
bioRxiv 721860; doi: https://doi.org/10.1101/721860
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14972)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28085)
- Molecular Biology (11592)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7340)
- Zoology (1651)